Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA3 | hg19_v2_chr10_+_8096769_8096787 | -0.81 | 1.1e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_29527702 | 13.55 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr10_-_49860525 | 7.51 |
ENST00000435790.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr3_-_127541194 | 7.10 |
ENST00000453507.2
|
MGLL
|
monoglyceride lipase |
chr2_+_228678550 | 7.04 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr19_+_4229495 | 6.71 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
chr3_-_79068594 | 5.80 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr15_+_67430339 | 5.57 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
chr9_-_123691047 | 5.53 |
ENST00000373887.3
|
TRAF1
|
TNF receptor-associated factor 1 |
chr2_-_89513402 | 5.48 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr9_-_123676827 | 5.32 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr5_+_131409476 | 5.20 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr6_+_32812568 | 5.17 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr4_+_74606223 | 5.15 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr12_-_57522813 | 4.87 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr6_-_29595779 | 4.83 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr5_-_146781153 | 4.78 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr9_-_123691439 | 4.70 |
ENST00000540010.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr5_-_150466692 | 4.56 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr15_+_67418047 | 4.55 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr19_+_10197463 | 4.46 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr11_+_19799327 | 4.39 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
chr16_-_11681023 | 4.10 |
ENST00000570904.1
ENST00000574701.1 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr6_-_31550192 | 4.06 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr6_-_160166218 | 3.98 |
ENST00000537657.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr11_-_102668879 | 3.96 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr8_+_54764346 | 3.86 |
ENST00000297313.3
ENST00000344277.6 |
RGS20
|
regulator of G-protein signaling 20 |
chr16_-_11681316 | 3.80 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
chr7_+_55177416 | 3.75 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr21_+_27011899 | 3.67 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
chr6_-_44233361 | 3.60 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr15_-_80263506 | 3.56 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr1_+_212738676 | 3.55 |
ENST00000366981.4
ENST00000366987.2 |
ATF3
|
activating transcription factor 3 |
chr12_-_52779433 | 3.51 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr11_+_35201826 | 3.43 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr16_-_67969888 | 3.42 |
ENST00000574576.2
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr1_-_184943610 | 3.34 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr11_+_69455855 | 3.24 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr3_+_72937182 | 3.16 |
ENST00000389617.4
|
GXYLT2
|
glucoside xylosyltransferase 2 |
chr2_-_208030647 | 3.13 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr2_+_127413704 | 3.07 |
ENST00000409836.3
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr5_+_113697983 | 3.01 |
ENST00000264773.3
|
KCNN2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr1_-_149908217 | 3.00 |
ENST00000369140.3
|
MTMR11
|
myotubularin related protein 11 |
chr17_+_41158742 | 2.95 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr1_-_149908710 | 2.94 |
ENST00000439741.2
ENST00000361405.6 ENST00000406732.3 |
MTMR11
|
myotubularin related protein 11 |
chr16_+_57023406 | 2.92 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr19_-_51527467 | 2.92 |
ENST00000593681.1
|
KLK11
|
kallikrein-related peptidase 11 |
chr14_+_21538517 | 2.91 |
ENST00000298693.3
|
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chrX_+_153455547 | 2.91 |
ENST00000430054.1
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive |
chr19_-_10464570 | 2.90 |
ENST00000529739.1
|
TYK2
|
tyrosine kinase 2 |
chr14_+_103592636 | 2.82 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr2_+_127413677 | 2.82 |
ENST00000356887.7
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr19_+_676385 | 2.82 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
chrX_+_128913906 | 2.81 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr2_-_202562716 | 2.80 |
ENST00000428900.2
|
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr12_+_113344755 | 2.79 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr1_+_79086088 | 2.78 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr12_+_113344582 | 2.74 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr12_-_57472522 | 2.72 |
ENST00000379391.3
ENST00000300128.4 |
TMEM194A
|
transmembrane protein 194A |
chr11_+_5423827 | 2.72 |
ENST00000332043.1
|
OR51J1
|
olfactory receptor, family 51, subfamily J, member 1 (gene/pseudogene) |
chr16_-_75590114 | 2.67 |
ENST00000568377.1
ENST00000565067.1 ENST00000258173.6 |
TMEM231
|
transmembrane protein 231 |
chr19_+_18284477 | 2.64 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr1_+_205225319 | 2.58 |
ENST00000329800.7
|
TMCC2
|
transmembrane and coiled-coil domain family 2 |
chr7_-_92777606 | 2.57 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
chr10_+_74451883 | 2.57 |
ENST00000373053.3
ENST00000357157.6 |
MCU
|
mitochondrial calcium uniporter |
chr5_+_131593364 | 2.54 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr21_+_37507210 | 2.50 |
ENST00000290354.5
|
CBR3
|
carbonyl reductase 3 |
chr9_+_74920335 | 2.49 |
ENST00000451596.2
ENST00000436054.1 |
RP11-63P12.6
|
RP11-63P12.6 |
chr16_+_57662138 | 2.48 |
ENST00000562414.1
ENST00000561969.1 ENST00000562631.1 ENST00000563445.1 ENST00000565338.1 ENST00000567702.1 |
GPR56
|
G protein-coupled receptor 56 |
chr2_-_220264703 | 2.44 |
ENST00000519905.1
ENST00000523282.1 ENST00000434339.1 ENST00000457935.1 |
DNPEP
|
aspartyl aminopeptidase |
chr10_+_91092241 | 2.40 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr11_+_20044600 | 2.39 |
ENST00000311043.8
|
NAV2
|
neuron navigator 2 |
chr11_+_63974135 | 2.39 |
ENST00000544997.1
ENST00000345728.5 ENST00000279227.5 |
FERMT3
|
fermitin family member 3 |
chr1_-_169703203 | 2.38 |
ENST00000333360.7
ENST00000367781.4 ENST00000367782.4 ENST00000367780.4 ENST00000367779.4 |
SELE
|
selectin E |
chr1_+_169079823 | 2.38 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr1_-_209824643 | 2.38 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr2_+_127413481 | 2.35 |
ENST00000259254.4
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr9_-_100881466 | 2.33 |
ENST00000341469.2
ENST00000342043.3 ENST00000375098.3 |
TRIM14
|
tripartite motif containing 14 |
chr11_-_57177586 | 2.32 |
ENST00000529411.1
|
RP11-872D17.8
|
Uncharacterized protein |
chr20_-_44176013 | 2.30 |
ENST00000555685.1
|
EPPIN
|
epididymal peptidase inhibitor |
chr18_+_61554932 | 2.27 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr22_-_31503490 | 2.25 |
ENST00000400299.2
|
SELM
|
Selenoprotein M |
chr12_+_56075330 | 2.23 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
chr12_+_121570631 | 2.21 |
ENST00000546057.1
ENST00000377162.2 ENST00000328963.5 ENST00000535250.1 ENST00000541446.1 |
P2RX7
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
chr10_-_101380121 | 2.21 |
ENST00000370495.4
|
SLC25A28
|
solute carrier family 25 (mitochondrial iron transporter), member 28 |
chr6_-_32820529 | 2.20 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr2_+_90108504 | 2.20 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr16_+_30212378 | 2.19 |
ENST00000569485.1
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chr5_+_35856951 | 2.19 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr22_+_21128167 | 2.19 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr22_-_36018569 | 2.17 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
chr10_-_105615164 | 2.15 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr5_-_141338627 | 2.15 |
ENST00000231484.3
|
PCDH12
|
protocadherin 12 |
chr6_+_126102292 | 2.14 |
ENST00000368357.3
|
NCOA7
|
nuclear receptor coactivator 7 |
chr18_-_71959159 | 2.14 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
chr3_-_64673289 | 2.14 |
ENST00000295903.4
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
chr9_+_74920408 | 2.12 |
ENST00000451152.1
|
RP11-63P12.6
|
RP11-63P12.6 |
chr15_+_71184931 | 2.12 |
ENST00000560369.1
ENST00000260382.5 |
LRRC49
|
leucine rich repeat containing 49 |
chr20_+_31805131 | 2.11 |
ENST00000375454.3
ENST00000375452.3 |
BPIFA3
|
BPI fold containing family A, member 3 |
chr5_+_96211643 | 2.10 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr4_-_114900831 | 2.09 |
ENST00000315366.7
|
ARSJ
|
arylsulfatase family, member J |
chr19_-_55660561 | 2.08 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr9_+_35732312 | 2.08 |
ENST00000353704.2
|
CREB3
|
cAMP responsive element binding protein 3 |
chr10_-_79397391 | 2.06 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr11_-_117748138 | 2.06 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr15_-_64338521 | 2.06 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr11_-_2950642 | 2.05 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr17_-_39280419 | 2.04 |
ENST00000394014.1
|
KRTAP4-12
|
keratin associated protein 4-12 |
chr14_+_55221541 | 2.04 |
ENST00000555192.1
|
SAMD4A
|
sterile alpha motif domain containing 4A |
chr20_-_62203808 | 2.03 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr7_+_18535786 | 2.02 |
ENST00000406072.1
|
HDAC9
|
histone deacetylase 9 |
chr7_-_22234381 | 2.02 |
ENST00000458533.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr21_+_26934165 | 2.01 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
chr12_-_52911718 | 2.00 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr4_+_142558078 | 2.00 |
ENST00000529613.1
|
IL15
|
interleukin 15 |
chr11_+_102188272 | 2.00 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr1_-_111743285 | 1.99 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr14_+_21538429 | 1.98 |
ENST00000298694.4
ENST00000555038.1 |
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr2_+_201997492 | 1.98 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr10_+_91152303 | 1.97 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr4_+_142557771 | 1.97 |
ENST00000514653.1
|
IL15
|
interleukin 15 |
chr14_-_91720224 | 1.96 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
chr5_-_150473127 | 1.95 |
ENST00000521001.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr1_-_154600421 | 1.95 |
ENST00000368471.3
ENST00000292205.5 |
ADAR
|
adenosine deaminase, RNA-specific |
chr3_-_16524357 | 1.95 |
ENST00000432519.1
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr7_-_107880508 | 1.94 |
ENST00000425651.2
|
NRCAM
|
neuronal cell adhesion molecule |
chr6_-_32806506 | 1.94 |
ENST00000374897.2
ENST00000452392.2 |
TAP2
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Uncharacterized protein |
chr16_+_2039946 | 1.94 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr6_+_29068386 | 1.94 |
ENST00000377171.3
|
OR2J1
|
olfactory receptor, family 2, subfamily J, member 1 (gene/pseudogene) |
chr2_+_102928009 | 1.92 |
ENST00000404917.2
ENST00000447231.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr7_-_105319536 | 1.92 |
ENST00000477775.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr11_-_72496976 | 1.91 |
ENST00000539138.1
ENST00000542989.1 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
chr17_+_47448102 | 1.91 |
ENST00000576461.1
|
RP11-81K2.1
|
Uncharacterized protein |
chr4_+_89299994 | 1.89 |
ENST00000264346.7
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr15_+_67458357 | 1.88 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr11_+_35211429 | 1.87 |
ENST00000525688.1
ENST00000278385.6 ENST00000533222.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_+_31555045 | 1.87 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
chr22_+_41697520 | 1.87 |
ENST00000352645.4
|
ZC3H7B
|
zinc finger CCCH-type containing 7B |
chr22_+_31608219 | 1.87 |
ENST00000406516.1
ENST00000444929.2 ENST00000331728.4 |
LIMK2
|
LIM domain kinase 2 |
chr11_+_102188224 | 1.87 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr12_+_113344811 | 1.85 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_-_4793274 | 1.85 |
ENST00000414938.1
|
EGOT
|
eosinophil granule ontogeny transcript (non-protein coding) |
chr12_-_11548496 | 1.85 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr6_+_4706368 | 1.84 |
ENST00000328908.5
|
CDYL
|
chromodomain protein, Y-like |
chr12_-_71182695 | 1.84 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr7_+_142919130 | 1.84 |
ENST00000408947.3
|
TAS2R40
|
taste receptor, type 2, member 40 |
chr2_+_201994042 | 1.83 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr21_+_43639211 | 1.82 |
ENST00000450121.1
ENST00000398449.3 ENST00000361802.2 |
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr16_+_30934376 | 1.80 |
ENST00000562798.1
ENST00000471231.2 |
FBXL19
|
F-box and leucine-rich repeat protein 19 |
chr17_+_56270084 | 1.79 |
ENST00000225371.5
|
EPX
|
eosinophil peroxidase |
chr3_+_11196206 | 1.79 |
ENST00000431010.2
|
HRH1
|
histamine receptor H1 |
chr1_+_206643787 | 1.79 |
ENST00000367120.3
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
chr4_-_74864386 | 1.79 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr4_+_89299885 | 1.78 |
ENST00000380265.5
ENST00000273960.3 |
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr17_+_26662597 | 1.78 |
ENST00000544907.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr3_+_11178779 | 1.76 |
ENST00000438284.2
|
HRH1
|
histamine receptor H1 |
chr19_-_10426663 | 1.76 |
ENST00000541276.1
ENST00000393708.3 ENST00000494368.1 |
FDX1L
|
ferredoxin 1-like |
chr3_-_123411191 | 1.75 |
ENST00000354792.5
ENST00000508240.1 |
MYLK
|
myosin light chain kinase |
chr1_-_173176452 | 1.74 |
ENST00000281834.3
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4 |
chr3_-_123339343 | 1.74 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
chr7_-_19184929 | 1.73 |
ENST00000275461.3
|
FERD3L
|
Fer3-like bHLH transcription factor |
chrX_-_63615297 | 1.73 |
ENST00000374852.3
ENST00000453546.1 |
MTMR8
|
myotubularin related protein 8 |
chr9_+_72658490 | 1.73 |
ENST00000377182.4
|
MAMDC2
|
MAM domain containing 2 |
chr11_-_5173599 | 1.73 |
ENST00000328942.1
|
OR52A1
|
olfactory receptor, family 52, subfamily A, member 1 |
chr16_+_67880820 | 1.72 |
ENST00000567105.1
|
NUTF2
|
nuclear transport factor 2 |
chr2_-_202562774 | 1.72 |
ENST00000396886.3
ENST00000409143.1 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr7_-_47579188 | 1.71 |
ENST00000398879.1
ENST00000355730.3 ENST00000442536.2 ENST00000458317.2 |
TNS3
|
tensin 3 |
chr3_-_123339418 | 1.71 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
chr3_-_11610255 | 1.70 |
ENST00000424529.2
|
VGLL4
|
vestigial like 4 (Drosophila) |
chr16_-_65155979 | 1.70 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr1_+_169764163 | 1.69 |
ENST00000413811.2
ENST00000359326.4 ENST00000456684.1 |
C1orf112
|
chromosome 1 open reading frame 112 |
chr22_+_22385332 | 1.68 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr5_+_135385202 | 1.68 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr17_-_28257080 | 1.67 |
ENST00000579954.1
ENST00000540801.1 ENST00000269033.3 ENST00000590153.1 ENST00000582084.1 |
SSH2
|
slingshot protein phosphatase 2 |
chr21_+_27011584 | 1.67 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr11_-_117747607 | 1.66 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr7_-_22233442 | 1.66 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr6_+_31554779 | 1.65 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr8_-_125577940 | 1.65 |
ENST00000519168.1
ENST00000395508.2 |
MTSS1
|
metastasis suppressor 1 |
chr11_-_57335750 | 1.64 |
ENST00000340573.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr6_+_31515337 | 1.64 |
ENST00000376148.4
ENST00000376145.4 |
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
chr11_+_71709938 | 1.63 |
ENST00000393705.4
ENST00000337131.5 ENST00000531053.1 ENST00000404792.1 |
IL18BP
|
interleukin 18 binding protein |
chr11_+_35211511 | 1.63 |
ENST00000524922.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr8_-_37756972 | 1.63 |
ENST00000330843.4
ENST00000522727.1 ENST00000287263.4 |
RAB11FIP1
|
RAB11 family interacting protein 1 (class I) |
chr1_+_206858328 | 1.61 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr6_-_11779014 | 1.61 |
ENST00000229583.5
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr22_-_36556821 | 1.61 |
ENST00000531095.1
ENST00000397293.2 ENST00000349314.2 |
APOL3
|
apolipoprotein L, 3 |
chr11_+_109964087 | 1.61 |
ENST00000278590.3
|
ZC3H12C
|
zinc finger CCCH-type containing 12C |
chr11_+_5710919 | 1.61 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr11_-_72492878 | 1.60 |
ENST00000535054.1
ENST00000545082.1 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
chr12_+_113354341 | 1.60 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr1_-_231005310 | 1.60 |
ENST00000470540.1
|
C1orf198
|
chromosome 1 open reading frame 198 |
chr12_-_56236734 | 1.59 |
ENST00000548629.1
|
MMP19
|
matrix metallopeptidase 19 |
chr11_-_3078616 | 1.59 |
ENST00000401769.3
ENST00000278224.9 ENST00000397114.3 ENST00000380525.4 |
CARS
|
cysteinyl-tRNA synthetase |
chr15_+_71185148 | 1.59 |
ENST00000443425.2
ENST00000560755.1 |
LRRC49
|
leucine rich repeat containing 49 |
chr11_-_57194948 | 1.58 |
ENST00000533235.1
ENST00000526621.1 ENST00000352187.1 |
SLC43A3
|
solute carrier family 43, member 3 |
chr15_-_55541227 | 1.58 |
ENST00000566877.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr17_-_79623597 | 1.58 |
ENST00000574024.1
ENST00000331056.5 |
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
chr11_-_441964 | 1.57 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr1_+_22307592 | 1.56 |
ENST00000400277.2
|
CELA3B
|
chymotrypsin-like elastase family, member 3B |
chr6_+_69345166 | 1.56 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.5 | GO:0070842 | aggresome assembly(GO:0070842) |
2.4 | 12.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
2.3 | 7.0 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.9 | 5.8 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
1.6 | 6.5 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
1.5 | 5.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.3 | 1.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
1.3 | 4.0 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
1.3 | 3.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.2 | 3.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
1.2 | 5.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.0 | 4.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.0 | 7.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.0 | 6.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
1.0 | 3.9 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
1.0 | 2.9 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
1.0 | 1.0 | GO:1903487 | regulation of lactation(GO:1903487) |
1.0 | 3.8 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.9 | 3.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.9 | 3.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.9 | 7.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.9 | 0.9 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.8 | 7.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.8 | 4.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.8 | 2.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.8 | 6.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.8 | 7.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.7 | 3.6 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.7 | 4.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.7 | 2.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.7 | 1.4 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.7 | 2.0 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.7 | 2.0 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.7 | 2.0 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.6 | 1.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.6 | 3.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.6 | 2.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.6 | 2.5 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 1.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.6 | 1.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 4.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 4.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 3.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.5 | 5.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.5 | 1.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
0.5 | 1.6 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.5 | 2.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.5 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 4.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 3.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 1.5 | GO:1903947 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.5 | 2.4 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.5 | 1.5 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.5 | 1.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 1.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 1.9 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.5 | 4.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 4.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.5 | 3.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 1.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 5.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.4 | 1.3 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.4 | 1.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.4 | 3.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 2.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.4 | 1.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.3 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.4 | 1.7 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.4 | 1.7 | GO:0035803 | egg coat formation(GO:0035803) |
0.4 | 2.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.4 | 2.9 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.4 | 1.2 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) right lung development(GO:0060458) |
0.4 | 1.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.4 | 0.8 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.4 | 1.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 2.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 1.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.4 | 1.2 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.4 | 1.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.4 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 0.8 | GO:2000974 | auditory receptor cell fate determination(GO:0042668) negative regulation of pro-B cell differentiation(GO:2000974) |
0.4 | 1.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 3.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 3.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.4 | 5.7 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 0.7 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.4 | 1.1 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.4 | 1.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 1.5 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 2.9 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.4 | 0.7 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.4 | 1.4 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 1.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 2.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.3 | 4.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.3 | 0.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 1.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 1.0 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.3 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.3 | 3.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 1.0 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.3 | 1.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.3 | 1.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.3 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 1.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.3 | 0.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.3 | 2.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.3 | 1.5 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.3 | 0.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.3 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 1.2 | GO:1904647 | response to rotenone(GO:1904647) |
0.3 | 0.9 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.3 | 3.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.3 | 1.2 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.3 | 0.9 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.3 | 0.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.3 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 2.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.3 | 1.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.3 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 2.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.3 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.8 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 0.3 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.3 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.3 | 0.8 | GO:1903412 | response to bile acid(GO:1903412) |
0.3 | 3.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.3 | 1.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 1.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 1.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 1.0 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 2.0 | GO:0001554 | luteolysis(GO:0001554) |
0.2 | 0.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 1.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 1.2 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.2 | 0.7 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.2 | 0.7 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 2.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 1.0 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.2 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.7 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 0.7 | GO:1990768 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.2 | 2.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.9 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 1.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 2.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.2 | 0.9 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 0.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 2.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 1.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 2.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 3.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.7 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.7 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 7.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.8 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.9 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.2 | 0.7 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.2 | 2.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 2.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 3.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.7 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 4.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.7 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.6 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.9 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.2 | 9.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.1 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 2.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 2.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.4 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.2 | 2.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 1.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.8 | GO:0010746 | response to high light intensity(GO:0009644) regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) cellular response to light intensity(GO:0071484) |
0.2 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.2 | 0.2 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 1.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.8 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.6 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 | 20.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 1.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 4.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.6 | GO:2000667 | positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 1.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.4 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 15.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 5.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.2 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.5 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.2 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 0.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 2.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 1.0 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 0.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 1.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.2 | 0.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.8 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 1.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.2 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.5 | GO:0051414 | response to cortisol(GO:0051414) |
0.2 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 2.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 2.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.3 | GO:1903431 | positive regulation of neuron maturation(GO:0014042) positive regulation of cell maturation(GO:1903431) |
0.2 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.3 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.2 | 2.9 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 1.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.1 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 1.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 3.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 1.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.1 | 0.4 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 1.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 1.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 1.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.1 | 1.3 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 1.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 1.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 1.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.4 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.8 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.4 | GO:0003218 | bundle of His development(GO:0003166) cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0042109 | negative regulation of tolerance induction(GO:0002644) lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.7 | GO:0060356 | leucine import(GO:0060356) |
0.1 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.4 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.8 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 3.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 1.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) regulation of osteoclast proliferation(GO:0090289) negative regulation of osteoclast proliferation(GO:0090291) regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.8 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.1 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.1 | 1.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.4 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.6 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.1 | 2.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 11.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.9 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.7 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.5 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 1.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.4 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.1 | 0.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.1 | 0.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 2.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.1 | 1.7 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 2.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.5 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 1.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 1.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.6 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 2.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 4.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 2.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.7 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 1.3 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.7 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.3 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 1.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 2.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:0090024 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.1 | 0.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 0.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 1.1 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 7.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 1.2 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.4 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 1.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 2.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.6 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 2.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.2 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.1 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.5 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 2.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.2 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 1.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.2 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 1.4 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.1 | 1.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 3.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 1.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 2.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.2 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.2 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 2.5 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.2 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.8 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 4.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.8 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 3.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
0.1 | 0.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.7 | GO:0014894 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.1 | 2.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 1.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.5 | GO:0046075 | dTTP metabolic process(GO:0046075) |
0.1 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 2.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.3 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 0.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.7 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 2.2 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.3 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 4.4 | GO:0021762 | substantia nigra development(GO:0021762) |
0.1 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.1 | 0.1 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.3 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 1.9 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 1.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 5.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.3 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.1 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.2 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 1.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.9 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 1.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 1.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 2.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.5 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.0 | GO:0048880 | noradrenergic neuron development(GO:0003358) sensory system development(GO:0048880) |
0.0 | 0.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.0 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.6 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 1.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.8 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.6 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.6 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.1 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.0 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 1.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 3.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 3.0 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.2 | GO:0010482 | ectoderm and mesoderm interaction(GO:0007499) epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.2 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.0 | 0.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 1.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.1 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 1.6 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 1.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.0 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 1.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 4.7 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 1.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 4.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.2 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) |
0.0 | 0.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.0 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.8 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.0 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 2.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.3 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.3 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.0 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.4 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.5 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 2.8 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.6 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
0.0 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.5 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.0 | 0.2 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 1.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.9 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.4 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.0 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.0 | 0.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.4 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.0 | 0.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.0 | 0.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.0 | 0.1 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.4 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.0 | GO:2001225 | regulation of anion channel activity(GO:0010359) regulation of chloride transport(GO:2001225) |
0.0 | 0.7 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.0 | 0.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0021503 | neural fold bending(GO:0021503) |
0.0 | 0.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.5 | 12.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.3 | 3.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
1.2 | 3.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.0 | 6.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.0 | 8.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.9 | 7.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.5 | 3.7 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.4 | 1.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.4 | 2.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.4 | 7.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 1.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.3 | 4.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.3 | 1.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 2.6 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 3.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 1.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 3.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 4.6 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.2 | 1.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 3.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.9 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 5.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.2 | 2.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 4.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 1.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 3.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 3.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 5.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.2 | 3.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 3.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.6 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.2 | 13.4 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 2.3 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.9 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.2 | 3.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 2.9 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.9 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 5.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.5 | GO:0060171 | myosin I complex(GO:0045160) stereocilium membrane(GO:0060171) |
0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 1.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 21.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.3 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 1.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 2.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 2.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 3.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 11.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 2.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 1.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 8.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0070985 | TFIIK complex(GO:0070985) |
0.1 | 1.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 3.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 3.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 3.7 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 1.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.4 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.1 | 10.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.8 | GO:0036019 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 1.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.1 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.0 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 1.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 1.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 6.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 5.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.0 | 1.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 6.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 2.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 1.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 4.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 3.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 7.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 22.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.9 | GO:0016605 | PML body(GO:0016605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 12.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
2.2 | 6.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.2 | 5.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 16.4 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 6.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.0 | 2.9 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.9 | 9.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.9 | 2.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 5.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 2.1 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.7 | 2.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.7 | 13.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 3.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 1.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 1.8 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.6 | 6.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 3.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 1.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.6 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.6 | 3.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 1.6 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.5 | 4.8 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.5 | 2.1 | GO:0030305 | heparanase activity(GO:0030305) |
0.5 | 3.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.5 | 1.6 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.5 | 0.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 2.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.5 | 2.5 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 2.0 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.5 | 1.9 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.4 | 1.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 1.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.4 | 4.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 5.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 3.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 7.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.4 | 3.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 2.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 3.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.4 | 2.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 4.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 2.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.4 | 1.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.4 | 2.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.4 | 1.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 3.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 4.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 2.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 2.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.0 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.3 | 1.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 1.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.3 | 1.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 0.9 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 4.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 9.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 2.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 0.9 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 1.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 0.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.3 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 9.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 8.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.3 | 3.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.3 | 4.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 1.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 3.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.3 | 1.5 | GO:0042835 | BRE binding(GO:0042835) |
0.3 | 1.0 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.3 | 1.0 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.3 | 4.6 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.3 | 0.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.3 | 0.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.2 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 0.7 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 0.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.2 | 4.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.2 | 1.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.9 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.2 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.9 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 3.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 0.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 4.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 2.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.8 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.2 | 4.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 0.6 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.2 | 20.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 4.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 5.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.8 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 7.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.5 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 1.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 3.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 2.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.7 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.2 | 1.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 0.5 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 0.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.2 | 0.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 2.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 2.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.4 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 1.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 1.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 1.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 4.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.1 | 0.5 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 4.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.9 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 5.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 6.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.6 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.1 | 1.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.5 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 0.3 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.1 | 1.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 2.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 3.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 0.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 3.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 2.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.7 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.3 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.1 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 2.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.6 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.1 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 3.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.5 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.4 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.1 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 1.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 3.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 4.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 1.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 8.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 2.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 1.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.2 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 5.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 4.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 2.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.9 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 4.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 7.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 1.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 2.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 2.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.0 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.4 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 3.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.0 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 1.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.4 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 2.5 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 4.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 6.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.6 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.5 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 2.0 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 2.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 11.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 1.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.2 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 1.0 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 4.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.0 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 2.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 0.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 30.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 3.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 9.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 9.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 6.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 8.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 8.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 5.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 8.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 9.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 6.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 11.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 3.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 4.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 4.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 3.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 6.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 3.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 22.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 2.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 3.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 3.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 12.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 8.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 13.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 7.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 9.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 10.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 6.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 16.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 4.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 4.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 5.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 5.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 16.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 13.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 5.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 14.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 5.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 6.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 6.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 8.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 4.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 3.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 4.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 3.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 4.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 8.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 3.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 2.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 11.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 2.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 1.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 2.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 4.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 2.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |